To evaluate the physiological relevance of CBS in colorectal carcinoma cells, we used the CRISPR/Cas9 gene editing method (28, 29) to prepare the DLD1 cell line with knocked-out CBS (DLDx). Here, CBS is linked to colorectal carcinoma.